Wakefit Innovations Limited: Monitoring Agency Report for Q3FY26 Shows No Utilization of Funds
Wakefit Innovations Limited's Monitoring Agency Report for Q3FY26 reveals no utilization of Pre-IPO (₹56 crore) or IPO (₹377.178 crore) proceeds during the quarter. Unutilized funds are parked in fixed deposits. All allocated funds for various purposes remain unutilized.
This is a routine compliance report and does not contain any new operational or financial performance data that would significantly impact the company's stock or investor sentiment.
The report is a routine regulatory filing that provides factual information about fund utilization. There are no positive or negative financial performance indicators or business developments mentioned.
Wakefit Innovations Limited has submitted its Monitoring Agency Report for the quarter ended December 31, 2025, as required by SEBI regulations.
The report, issued by CARE Ratings Limited, covers the utilization of proceeds from both the Pre-Initial Public Offer (IPO) and the Initial Public Offer (IPO) of the company.
For the Pre-IPO placement of ₹56.00 crore, the report indicates that no funds were utilized during the third quarter of FY26. The unutilized amount has been parked in fixed deposits. The total allocated amount for general corporate purposes remains ₹56.00 crore, with nil utilization to date.
Similarly, for the IPO of ₹377.178 crore, the Monitoring Agency Report confirms that no funds were utilized during the quarter ended December 31, 2025. The entire IPO proceeds are parked in fixed deposits and the Public Issue account, with ₹377.178 crore remaining unutilized. The allocated amounts for various purposes, including capital expenditure for new stores, lease and license fees, equipment purchase, marketing, and general corporate purposes, have all seen nil utilization during the quarter.
The company's website at www.wakefit.co/investor-relations will also host this information.
What to do with a filing like this
Wakefit Innovations Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Wakefit Innovations Limited. Read the original for the full detail.